Site Logo Conselho Brasileiro de Oftalmologia
Original Articles
Views

Arq. Bras. Oftalmol. 2018; 81 (4): 10.5935/0004-2749.20180062

Total: 1572

Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery

Christiana Rebello Hilgert1,2; Alvaro Haverroth Hilgert2; Alexandre Nakao Odashiro3,4; Patricia Rusa Pereira Odashiro1,5; Augusto Paranhos Jr.1

DOI: 10.5935/0004-2749.20180062

1. Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo, SP, Brazil
2. Instituto da Visão de Mato Grosso do Sul, Campo Grande, MS, Brazil
3. Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
4. Department of Pathology, Molecular Biology and Microbiology, University Laval, Quebec, Canada
5. Centre de Recherche d’Ínstitut Universitaire de Cardiologie et de Pneumologie, University Laval, Quebec, Canada

Corresponding author

Christiana Rebello Hilgert
Instituto da Visão de Mato Grosso do Sul
Av. Rubens Gil de Camillo, 83
Campo Grande, MS - 79040-090 - Brazil
E-mail: [email protected]

Funding: No specific financial support was available for this study

Disclosure of potential conflicts of interest: None of the authors have any potential conflict of interest to disclose


Read in Portuguese XML Print PDF English
Open Access
Share

How to cite this article:

Hilgert1 CR, 2 , Hilgert AH, Odashiro3 AN, 4 , Odashiro1 PRP, et al. Efeito antifibrótico do uso intraoperatório de bevacizumab em cirurgia filtrante experimental. Arq. Bras. Oftalmol. 2018;81(4):. 10.5935/0004-2749.20180062
Export citation

Dimensions

Altmetric

PlumX